Home
INI CET
Pharmacology

Filters

Found 1 Question

Set Default

Exams

INI CET

Years

2026

Subjects

Pharmacology

Topics

Cardiac involvement in systemic sclerosis (myocardial fibrosis)
Anti-ageing drugs and molecular targets
Antiplatelet drugs - ticagrelor (P2Y12 inhibitor)
Beta thalassemia major pathophysiology
Fenfluramine adverse effects and monitoring
GPCR signalling - G-protein coupling of receptors
Geriatrics - frailty and sarcopenia
Geriatrics - risk factors for falls in the elderly
Histology special stains - liver fibrosis
Microcytic anemia diagnosis (iron deficiency)
Receptor types / ligand-gated ion channels
Renin secretion control (RAAS)
Smoking cessation - nicotine replacement therapy
Targeted anticancer therapy - tyrosine kinase inhibitors
Therapeutic index from quantal dose-response curve
Vasculitis classification by vessel size
Wilson disease and copper chelation therapy

List of top Pharmacology Questions on Cardiac involvement in systemic sclerosis (myocardial fibrosis) asked in INI CET

Which cardiac abnormality is most characteristically associated with systemic sclerosis (scleroderma)?

INI CET - 2026
INI CET
Pharmacology
Cardiac involvement in systemic sclerosis (myocardial fibrosis)

terms & conditions

Privacy & Policy

© 2026 Patronum Web Private Limited